(Q44108848)

29 November 2017

Comparison of nevirapine- and efavirenz-containing antiretroviral regimens in antiretroviral-naïve patients: a cohort study (English)

1 reference

29 November 2017

anti-retroviral agent

0 references

1 reference

Philip Keiser

1

1 reference

29 November 2017

Naiel Nassar

2

1 reference

29 November 2017

Clinton White

3

1 reference

29 November 2017

Glenda Koen

4

1 reference

29 November 2017

Sylvia Moreno

5

1 reference

29 November 2017

1 July 2002

1 reference

29 November 2017

1 reference

29 November 2017

3

1 reference

29 November 2017

4

1 reference

29 November 2017

296-303

1 reference

British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy

29 November 2017

1 reference

https://api.crossref.org/works/10.1310%2FM47B-R51C-X0MC-K3GW

Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. February 5, 2001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FM47B-R51C-X0MC-K3GW

Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 Team

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FM47B-R51C-X0MC-K3GW

Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: role of hepatitis C and B infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FM47B-R51C-X0MC-K3GW

Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FM47B-R51C-X0MC-K3GW

The tolerability of efavirenz after nevirapine-related adverse events

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FM47B-R51C-X0MC-K3GW

Virological suppression at 6 months is related to choice of initial regimen in antiretroviral-naive patients: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FM47B-R51C-X0MC-K3GW

Why data bases should not replace randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FM47B-R51C-X0MC-K3GW

Randomized versus historical controls for clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FM47B-R51C-X0MC-K3GW

Use of observational databases to evaluate the effectiveness of antiretroviral therapy for HIV infection: comparison of cohort studies with randomized trials. EuroSIDA, the French Hospital Database on HIV and the Swiss HIV Cohort Study Groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FM47B-R51C-X0MC-K3GW

Randomized, controlled trials, observational studies, and the hierarchy of research designs

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FM47B-R51C-X0MC-K3GW

A comparison of observational studies and randomized, controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FM47B-R51C-X0MC-K3GW

10.1310/M47B-R51C-X0MC-K3GW

21 January 2018

Identifiers

DOI

1 reference

29 November 2017

1 reference